IgA Nephropathy Market is Set to Grow Substantially in Upcoming Years - BIS Research

What is IgA Nephropathy? 

IgA Nephropathy, also known as Berger’s disease, is a chronic kidney disorder caused by the buildup of the antibody immunoglobulin A (IgA) in the kidneys. This accumulation leads to inflammation, which can impair the kidneys' ability to filter waste from the blood. The disease progresses at varying rates, potentially leading to end-stage renal failure in severe cases. While often slow-developing, early diagnosis and management are critical to delay progression. 

What is the Current Market Outlook for IgA Nephropathy? 

The global IgA nephropathy market is in a growth phase, driven by rising disease awareness, improved diagnostics, and the introduction of advanced renal therapies. From 2025 to 2035, the market is expected to grow significantly, fueled by R&D investments, clinical trials, and faster regulatory approvals for novel drugs. North America is projected to lead the market, backed by robust healthcare infrastructure, a high prevalence of kidney disorders, and favorable regulatory conditions. 

What is the key Innovation & Trends in IgA Nephropathy Market? 

The IgA nephropathy market is growing, driven by advancements in diagnostics and the development of novel therapies like complement inhibitors and non-immunosuppressive drugs. Regulatory bodies are accelerating approvals, with key innovations such as FDA approvals for Novartis’ Vanrafia and Travere Therapeutics' FILSPARI boosting treatment accessibility. 

How Does This Report Help Organizations Drive Strategic Growth? 

• Provides market growth insights: Helps understand the expanding IgA nephropathy market and key drivers. 
• Highlights regulatory trends: Outlines recent approvals and regulatory activities impacting treatment availability. 
• Identifies key innovations: Focuses on novel therapies and diagnostic advancements shaping the market. 
• Highlights regional growth: Shows North America’s dominance in the market due to infrastructure and awareness. 
• Recognizes strategic collaborations: Showcases industry partnerships supporting real-world evidence initiatives. 

Explore the Full TOC and Download Report Sample >>  

What Are the Key Demand Drivers and Challenges in the IgA Nephropathy Market? 

Drivers: 

• Increasing Prevalence of IgA Nephropathy  

• Continuous Advancements in Treatment Options  

• Improved Diagnosis and Awareness 

Challenges:  

• High Treatment Costs 

• Limited Awareness in Developing Markets   

What Is the Competitive Landscape in IgA Nephropathy Market? 

Key Players 

• Novartis 

• F. Hoffmann-La Roche 

• Ionis Pharmaceuticals 

• Vertex Pharmaceuticals 

• Otsuka Pharmaceutical 

• Biogen 

• Arrowhead Pharmaceuticals 

• NovelMed 

• Q32 Bio 

• Walden Biosciences 

• Takeda Pharmaceutical 

• Vera Therapeutics 

• Biocity Biopharmaceutics Co., Ltd. 

• Calliditas Therapeutics AB 

• Travere Therapeutics, Inc. 

• Alexion Pharmaceuticals, Inc. 

• Other Companies 

Strategic Initiatives 

To accelerate growth in the IgA nephropathy market, pharmaceutical companies should focus on increasing R&D investments, leveraging regulatory advantages for faster drug approvals, and forming strategic partnerships to advance patient-centric treatments. Companies should also collaborate with healthcare providers to improve awareness, particularly in underserved markets, while working to reduce the high treatment costs associated with new therapies. 

Here Are Some Case Studies and Success Stories in IgA Nephropathy Market 

In March 2025, Folia Health and Novartis Pharmaceuticals collaborated to launch an at-home observational real-world evidence initiative. This partnership aims to support individuals with IgA nephropathy by providing a platform for better disease management and enhancing treatment outcomes through data-driven insights. This strategic initiative exemplifies how collaboration between pharmaceutical companies and health-tech innovators can bridge the gap in IgA nephropathy care and foster long-term market growth. 

[Schedule a Call with Industry Experts] 

[Download Complete TOC] 

Related Reports from BIS Research 

Continuous Renal Replacement Therapy Market  

Metastatic Colorectal Cancer Market     

Hereditary Angioedema Market       

About BIS Research 

BIS Research is a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends, which can disrupt the market dynamics in the near future. We publish over 200 market intelligence studies annually, focusing on several deep technology verticals.   

Our strategic market analysis emphasizes market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.    

BIS Research offers syndicate and custom studies and expert consultations to firms, providing them with specific and actionable insights on novel technology markets, business models, and competitive landscapes.   

Contact 

Head of Marketing   

Email: media@bisresearch.com    

BIS Research Inc.   

39111 PASEO PADRE PKWY STE 313,   

FREMONT, CA 94538-1686   

Visit our Blog @https://bisresearch.com/insights   

Get Expert Insights @https://community.insightmonk.com    

Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research    

Connect with us on Twitter@ https://twitter.com/BISResearch